| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |